Cost of Revenue in USD of QLY Biotech Group Corp. from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
QLY Biotech Group Corp. quarterly/annual Cost of Revenue history and growth rate from Q1 2019 to Q1 2023.
  • QLY Biotech Group Corp. Cost of Revenue for the quarter ending February 28, 2023 was $0.000.
  • QLY Biotech Group Corp. annual Cost of Revenue for 2022 was $0.000, a 100% decline from 2021.
  • QLY Biotech Group Corp. annual Cost of Revenue for 2021 was $1.4K, unchanged from 2020.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)

QLY Biotech Group Corp. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 Dec 1, 2022 Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $0 $0 Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-13
Q1 2022 $0 Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-13
Q4 2021 $0 $0 Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-13
Q4 2020 $0 Sep 1, 2020 Nov 30, 2020 10-Q 2021-12-13
Q1 2020 $1.4K +$1.4K Dec 1, 2019 Feb 29, 2020 10-Q 2020-04-09
Q1 2019 $0 Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-09

QLY Biotech Group Corp. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 -$1.4K -100% Sep 1, 2021 Aug 31, 2022 10-K 2022-12-14
2021 $1.4K $0 0% Sep 1, 2020 Aug 31, 2021 10-K 2022-12-14
2020 $1.4K Sep 1, 2019 Aug 31, 2020 10-K 2021-11-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.